Mediclinic International Plc. (MDC:LN) (ANHGY) PT Raised to GBP3.20 at Morgan Stanley
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
Morgan Stanley analyst Roy Campbell raised the price target on Mediclinic International Plc. (MDC:LN) (OTC: ANHGY) to GBP3.20 (from GBP3.10) while maintaining a Equalweight rating.
You May Also Be Interested In
- UPDATE: UBS Upgrades EnLink Midstream, LLC (ENLC) to Buy
- Tsingtao Brewery Company Limited (168:HK) (TSGTF) PT Raised to HK$86.20 at Goldman Sachs
- Avast Plc. (AVST:LN) (AVASF) PT Raised to GBP p 615 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Intl Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!